Murray Dallan bought SRPT
March 10, 2025 · Form 4 insider transaction
Murray Dallan bought 8,276 shares of Sarepta Therapeutics, Inc., a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
8,276
Price
N/A
Total value
N/A
InsiderMurray Dallan
RoleOfficer
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateMarch 10, 2025
Filing dateMarch 11, 2025
Shares owned after38,202
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The Reporting Person was granted restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock. 25% of the shares of common stock underlying each RSU will vest on the first anniversary of the grant date, and additional 25% will vest on each anniversary of the Grant Date thereafter, such that the RSUs will be fully vested on the fourth anniversary of the grant date.